ANTHONY Y. SUN - President & CEO, Director at Zentalis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Issuer Symbol
ZNTL on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by ANTHONY Y. SUN since 15 Feb 2025

Holdings reported by ANTHONY Y. SUN for Zentalis Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,175,589 $12,096,341 $10.29 05 Apr 2022 Direct
Common Stock 974,302 $10,025,178 $10.29 04 Apr 2022 By Essex Group International, LLC
Stock Option (Right to Buy) 118,319 $5,655,648 $47.80 10 Feb 2022 Direct Common Stock
Common Stock 213,600 $2,197,859 $10.29 04 Apr 2022 By Hao Bao Zi Trust LLC
Common Stock 125,000 $1,286,200 $10.29 04 Apr 2022 By Hao Jiao Zi Trust LLC
Common Stock 103,650 $1,066,517 $10.29 04 Apr 2022 By Spouse

Transactions reported by ANTHONY Y. SUN for Zentalis Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.